Page 8 - Decision Diagnostics Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Decision diagnostics corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Decision Diagnostics Corp Today - Breaking & Trending Today

Decision Diagnostics Corp.: DECN to Announce Various Testing Results This Week for Its COVID-19 GenViro! Swift Kit


(2)
The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test results it has amassed demonstrating the technology s promise
LOS ANGELES, CA / ACCESSWIRE / December 21, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., as well as the designer and manufacturer of the proposed GenViro! Covid-19 :10 test kits, today announced it is proceeding with final testing of the GenViro! Covid-19 Saliva Swift Kit and will continue in its efforts to bring this valuable technology to market. Initially, the company will be releasing a series of test results collected from its Korean partner, from the detailed XPRIZE sample testing and as it becomes available, from its US-based testing, all of which will be submitted to the FDA for ....

Puerto Rico , United States , Russian Federation , Keith Berman , Pharma Tech Solutions Inc , Decision Diagnostics Corp , Decision Diagnostics , Pharma Tech Solutions , Swift Kit , Saliva Swift Kit , Monday December , Looking Statements , ப்வெர்டோ ரிக்கோ , ஒன்றுபட்டது மாநிலங்களில் , ரஷ்ய கூட்டமைப்பு , கேய்ட் பெர்மன் , பார்மா தொழில்நுட்பம் தீர்வுகள் இன்க் , முடிவு பரிசோதனை கார்ப் , முடிவு பரிசோதனை , பார்மா தொழில்நுட்பம் தீர்வுகள் , ஸ்விஃப்ட் கிட் , உமிழ்நீர் ஸ்விஃப்ட் கிட் , திங்கட்கிழமை டிசம்பர் , பார்க்கிறது அறிக்கைகள் ,

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm


Home / Top News / SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm
PHILADELPHIA, Dec. 19, 2020 (GLOBE NEWSWIRE) Kaskela Law LLC announces that it is investigating Decision Diagnostics Corp. (“Decision Diagnostics”) (OTC: DECN) on behalf of the company’s stockholders.
On December 17, 2020, the U.S. Securities and Exchange Commission (“SEC”) filed a complaint against Decision Diagnostics and its Chief Executive Officer (“CEO”), Keith Berman, in the U.S. District Court for the Southern District of New York. The complaint alleges that Decision Diagnostics and Berman seized upon the Covid-19 global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood te ....

New York , United States , Newtown Square , Keith Berman , D Seamus Kaskela , Exchange Commission , Decision Diagnostics Corp , Kaskela Law , Us District Court , Decision Diagnostics , Chief Executive Officer , Southern District , Decision Diagnostic , Seamus Kaskela , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதிய நகரம் சதுரம் , கேய்ட் பெர்மன் , ட சீமஸ் காஸ்கேல , பரிமாற்றம் தரகு , முடிவு பரிசோதனை கார்ப் , காஸ்கேல சட்டம் , எங்களுக்கு மாவட்டம் நீதிமன்றம் , முடிவு பரிசோதனை , தலைமை நிர்வாகி அதிகாரி , தெற்கு மாவட்டம் ,

DECN Comments on Recent Legal Filings by Federal Agencies – IT Business Net

SEC Alleges Biotechnology Company Falsely Claimed it Developed 'Break-through' COVID-19 Test


December 18, 2020
On Thursday in the Southern District of New York, the Securities and Exchange Commission (SEC) filed a complaint against Keith Berman and Decision Diagnostics Corp. (DECN), alleging that the defendants made false and misleading public statements in the spring that they had developed a “break-through” finger-pricking device to test for the novel coronavirus when they actually had not finished the product nor even developed a prototype.
In mid-February, Berman, president and CEO of biotechnology company DECN, learned of the location of DECN’s manufacturing site for its glucose testing strip for diabetes and decided to pursue the development of a coronavirus testing kit the first time the company had attempted to create a virus detection test according to the complaint. ....

New York , United States , Keith Berman , Exchange Commission , Decision Diagnostics Corp , Southern District , Decision Diagnostics , Exchange Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , கேய்ட் பெர்மன் , பரிமாற்றம் தரகு , முடிவு பரிசோதனை கார்ப் , தெற்கு மாவட்டம் , முடிவு பரிசோதனை , பரிமாற்றம் நாடகம் ,